SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSigmaroc. Regulatory News (SRC)

Share Price Information for Sigmaroc. (SRC)

Share Price is delayed by 15 minutes
Get Live Data
125.20    5.90 (4.95%)
Bid:
125.10
Ask:
125.40
Spread: 0.30 (0.24%)
Market Cap: £1.39b
SRC Live PriceLast checked at - London Stock Exchange

Intraday Sigmaroc. Share Chart

Admission to AIM

4 Jan 2024 08:15

RNS Number : 5881Y
SigmaRoc PLC
04 January 2024
 

4 January 2024

 

SIGMAROC PLC

 

("SigmaRoc", the "Company" or the "Group")

 

Admission to AIM

 

SigmaRoc (AIM: SRC), the AIM quoted lime and limestone group, is pleased to announce the Admission of its Enlarged Share Capital, comprising 693,801,899 Existing Ordinary Shares, 418,464,565 Placing Shares and 2,588,066 REX Intermediaries Offer Shares, to trading on AIM effective from 8.00 a.m. on 4 January 2024 and completion of the acquisition of the Deal 1 Targets.

 

Highlights of the Acquisitions

 

· Provide an opportunity to become Northern Europe's leader in lime and a key supplier to the structural growth markets critical for the green transition.

· Lime and limestone are key resources in the transition to a more sustainable economy. New applications for lime and limestone products as part of a drive for sustainability include the production and recycling of lithium batteries, the decarbonisation of construction including through substitution of cementitious material and new building materials, and environmental applications including lake liming, air pollution and direct air capture.

· The lime market is expected to continue to grow and to be worth ?1.9 billion in 2031 across the Enlarged Group's markets.

· Pro forma revenue of the Enlarged Group for FY22 would be £1 billion with underlying EBITDA of £211 million (assuming, in each case, exercise of the UK Call Option and Polish Call Option).

· The Enlarged Group is expected to be significantly cash generative with a free cash flow target in excess of £100 million per annum which is expected to enable the Enlarged Group to de-gear at a rate of 0.5x per year with target leverage of 1.0x.

· The Targets, together, have a consistent performance track record delivering FY22 revenue of ?579.7 million and EBITDA of ?133.7 million and EBITDA margin in excess of 20 per cent.

· Expected to deliver revenue growth opportunities and cost synergies resulting in at least ?30 million of EBITDA contribution by 31 December 2027.

· The Targets are aligned with SigmaRoc's ESG and net zero ambitions.

· Whereas the Deal 1 Targets are stand-alone entities, the Call Option Targets (being the UK Target and the Polish Target) require carving out of existing CRH businesses in order to be acquired.

· Total consideration payable by the Company for the Deal 1 Targets is ?745 million (approximately £645 million).

 

Trading

 

SigmaRoc has continued to trade well since the October Q3 update. The Company will provide fuller commentary later in January with results expected to be at least in line with market expectations*.

 

Defined terms used throughout this announcement have the meanings set out in the admission document published by the Company on 23 November 2023 unless the context requires otherwise.

 

*Consensus expectations for SigmaRoc, being the average of forecasts for the year ending 31 December 2023 provided by analysts covering the Company, are revenue of £596.9m and underlying EBITDA of £110.2m.

 

 

Information on SigmaRoc is available on the Company's website at: www.sigmaroc.com.

 

For further information, please contact:

 

SigmaRoc plc

Max Vermorken (Chief Executive Officer)

Garth Palmer (Chief Financial Officer)

Tom Jenkins (Head of Investor Relations)

 

Tel: +44 (0) 207 002 1080

ir@sigmaroc.com 

 

Liberum Capital Limited (Nominated and Financial Adviser, Joint Bookrunner and Co-Broker)

Dru Danford / Ben Cryer / Mark Harrison / John More / Anake Singh

Tel: +44 (0) 203 100 2000

 

Peel Hunt (Joint Bookrunner and Co-Broker)

Investment Banking

Mike Bell / Ed Allsopp / Ben Harrington

ECM Syndicate & Broking

Sohail Akbar / Jock Maxwell Macdonald / Tom Ballard

Tel: +44 (0) 20 7418 8900

 

Walbrook PR Ltd (Public Relations)

Tel: +44 20 7933 8780 /

Tom Cooper / Nick Rome

sigmaroc@walbrookpr.com

Mob: +44 7748 325 236 (Nick)

 

About SigmaRoc plc

SigmaRoc is an AIM-quoted lime and limestone group targeting quarried materials assets in the UK and Northern Europe. It seeks to create value by purchasing assets in fragmented materials markets and extracting efficiencies through active management and by forming the assets into larger groups. It seeks to de-risk its investments through the selection of projects with strong asset-backing.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUPUUCGUPCPGW
Date   Source Headline
15th Jun 20267:00 amRNSShare Purchase by Director
2nd Jun 202610:27 amRNSTR-1: Notification of Major Holdings
1st Jun 20261:51 pmRNSTR-1: Notification of Major Holdings
30th Apr 20263:37 pmRNSAGM Result
30th Apr 20267:00 amRNSAGM Statement
20th Apr 20267:00 amRNSTR-1: Notification of Major Holdings
9th Apr 20263:21 pmRNSPDMR Dealing
31st Mar 20267:00 amRNSNew debt facility
26th Mar 20267:00 amRNSShare Purchases by Director
19th Mar 20267:00 amRNSShare Purchases by Directors
18th Mar 20269:55 amRNSEmployee Benefit Trust Share Purchase
16th Mar 202610:58 amRNSAnnouncement of Option and LTIP awards
16th Mar 202610:58 amRNSAnnouncement of Option and LTIP awards
16th Mar 20267:00 amRNSFull Year Results and Notice of AGM
16th Mar 20267:00 amRNSFull Year Results and Notice of AGM
10th Mar 20265:52 pmRNSTR-1: Notification of Major Holdings
10th Mar 20265:52 pmRNSTR-1: Notification of Major Holdings
3rd Mar 20268:00 amRNS-RSkreenHouse Litherm
3rd Mar 20267:00 amRNSNotice of Results
23rd Feb 20263:59 pmRNSTR-1: Notification of Major Holdings
28th Jan 20263:40 pmRNSTR-1: Notification of Major Holdings
23rd Jan 20267:00 amRNSExercise of options and sale of shares by PDMRs
19th Jan 20267:00 amRNSYear-end trading update
7th Jan 202611:25 amRNSTR-1: Notification of Major Holdings
17th Dec 20255:41 pmRNSTR-1: Notification of Major Holdings
25th Nov 202512:06 pmRNSTR-1: Notification of Major Holdings
21st Oct 20257:00 amRNSQ3 Trading Update
16th Sep 20257:00 amRNSUpdate in relation to the AMeLi project
8th Sep 20257:25 amRNSInterim Results
27th Aug 20257:00 amRNSTR-1: Notification of Major Holdings
12th Aug 20252:57 pmRNSTR-1: Notification of Major Holdings
11th Aug 20251:17 pmRNSTR-1: Notification of Major Holdings
6th Aug 20253:51 pmRNSTR-1: Notification of Major Holdings
24th Jul 20257:00 amRNSInterim Results, Analyst Briefing & Investor Pres
15th Jul 20257:00 amRNSTR-1: Notification of Major Holdings
11th Jul 20259:45 amRNSHolding(s) in Company
9th Jul 20253:16 pmRNSHolding(s) in Company
3rd Jul 20253:28 pmRNSTR-1: Notification of Major Holdings
10th Jun 20259:15 amRNS-RSeed funding of Koncrete
15th May 202511:48 amRNSDirector/PDMR Shareholding
7th May 20257:00 amRNSCapital Markets Day
1st May 20254:01 pmRNSAGM Result
1st May 20257:00 amRNSAGM Statement
25th Apr 20257:00 amRNS-RPartnership with Adaptavate
10th Apr 20252:18 pmRNSAwards under SIP to Directors and PDMRs
1st Apr 20257:00 amRNSNotice of AGM and Posting of Annual Report
20th Mar 202510:29 amRNSTR-1: Notification of Major Holdings
17th Mar 20257:01 amRNSCapital Markets Day
17th Mar 20257:00 amRNSFull Year Results
27th Feb 20257:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.